Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD)

Conditions: Pompe Disease (Late-onset) Interventions: Genetic: CRG003 injection Sponsors: Huashan Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials